| Direct Competitor Comparison | |
|---|
| BMY | AZN | MRK | RHHBY | Industry |
|---|
| Market Cap: | 72.17B | 64.61B | 142.45B | 219.96B | 64.52B |
|---|
| Employees: | 28,000 | 51,700 | 83,000 | 82,089 | 99.49k |
|---|
| Qtrly Rev Growth (yoy): | -0.27 | -0.13 | -0.09 | 0.12 | 0.11 |
|---|
| Revenue (ttm):
| 16.20B | 27.01B | 46.21B | 50.83B | 27.01B |
|---|
| Gross Margin (ttm): | 0.75 | 0.81 | 0.65 | 0.75 | 0.61 |
|---|
| EBITDA (ttm): | 4.62B | 11.09B | 16.36B | 20.10B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.22 | 0.33 | 0.21 | 0.34 | 0.16 |
|---|
| Net Income (ttm): | 1.47B | 5.68B | 6.02B | 10.22B | N/A |
|---|
| EPS (ttm): | 0.88 | 4.52 | 1.96 | 2.99 | 3.27 |
|---|
| P/E (ttm): | 49.76 | 11.45 | 24.07 | 21.69 | 14.20 |
|---|
| PEG (5 yr expected): | 2.45 | -1.01 | 5.21 | 2.31 | 0.96 |
|---|
| P/S (ttm): | 4.44 | 2.38 | 2.95 | 4.24 | 2.23 |
|---|
|
| AZN = AstraZeneca PLC | | MRK = Merck & Co. Inc. | | RHHBY = Roche Holding AG | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.63 | 0.02 | 78.30B | 17.71 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 232.59 | 0.03 | 54.94B | 36.91 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 56.70 | 0.02 | 86.09B | 31.75 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.64 | 0.00 | 12.68B | 31.18 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.00 | 34.30B | 20.08 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 130.04 | 0.02 | 16.56B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.25 | -0.00 | 11.91B | 20.88 |
|---|
| Pfizer Inc. | PFE | 28.81 | 0.00 | 203.61B | 13.79 |
|---|
| Johnson & Johnson | JNJ | 88.32 | 0.00 | 248.05B | 23.99 |
|---|
| GlaxoSmithKline plc | GSK | 52.67 | 0.01 | 127.47B | 19.25 |
|---|
| Sanofi | SNY | 55.00 | 0.02 | 145.31B | 27.11 |
|---|
| Novartis AG | NVS | 74.60 | 0.01 | 183.14B | 18.93 |
|---|
| Roche Holding AG | RHHBY | 64.81 | 0.02 | 219.96B | 21.69 |
|---|
| AstraZeneca PLC | AZN | 51.75 | 0.00 | 64.61B | 11.45 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.73 | -0.00 | 58.74B | 11.50 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.94 | 0.00 | 72.17B | 49.76 |
|---|
|
| News on Direct Competitors | |
|---|
- AZN
- The Top 3 Diseases Caused by Stress at Motley Fool Tue 2:28pm
- AZN
- 3 Neil Woodford High-Yield Shares at Motley Fool Tue 10:48am
- MRK
- Finding the Next Big Blockbuster Drug Accesswire Thu, May 16
- MRK
- StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX Accesswire Wed, May 15
- MRK
- Analysis: Drugmakers face more scrutiny of discordant U.S. prices Reuters Fri, May 10
- MRK
- Leading Active Companies in the News: Crown Marketing (CWNM), Nuvilex (NVLX), Elite Pharmaceuticals (ELTP), Cannabis Science (CBIS), Merck (MRK) Accesswire Thu, May 9
- AZN
- GSK, AZN, KERX, and RPTP Early Briefing and Review Accesswire Thu, May 2
- MRK
- Traders Favorite: Keryx Biopharmaceuticals, McDonald's Corporation, Merck & Co, Hertz Global Holdings Accesswire Mon, Apr 22
- RHHBY
- News And Analysis Reports On: (OTCQX: RHHBY), (OTC Pink: NSRGY) Accesswire Mon, Apr 22
- RHHBY
- Petro Bakken Energy Ltd. And Roche Holding Ltd. Reports: (OTC Pink: PBKEF), (OTCQX: RHHBY) Accesswire Thu, Apr 18
- AZN
- Sizzling Stocks: AstraZeneca plc, Zynga Inc, Rigel Pharmaceuticals Accesswire Fri, Apr 5
- AZN
- Sizzling Movers: Arena Pharmaceuticals, AstraZeneca plc, Google Inc Accesswire Fri, Mar 22
- RHHBY
- Pacific Therapeutics Ltd. Issues Stock Options to Directors and Officers Accesswire Fri, Dec 21
- RHHBY
- Penny Stocks Watch-List Traders Should Be Aware Of: (OTCQB: KWBT), (OTCQB: RHHBY) Accesswire Mon, Dec 3
- RHHBY
- Breast Cancer News: Geron Drug Fails, Herceptin® May Increase Heart Problems, Sunshine Biopharma Heading for Clinical Trials Accesswire Thu, Sep 20
All headlines for these symbols... Currency in USD. | |
|
0.18(0.41%) 3:50PM EDT - Nasdaq Real Time Price